Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents

Overview of attention for article published in Frontiers in Pharmacology, August 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 1 X user

reddit: 2 Redditors

Summary X Reddit

So far, Altmetric has seen 2 Reddit threads by 2 users.

Frontiers | Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents

User WalkingHorse, in the LungCancerSupport subreddit, 06 Aug 2024

Optimizing First-Line TKI Treatment Efficacy in PD-L1-Positive EGFR-Mutated NSCLC: The Impact of Antiangiogenic Agents

User montaukwhaler, in the non small cell lung cancer subreddit, 30 Jul 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.